Predictive Value of Prostate-specific Antigen, Tumour Stage and Tumour Grade for the Outcome of Bone Scintigraphy in Patients with Newly Diagnosed Prostate Cancer

By Rydh Anders   Tomic Radisa   Tavelin Björn   Hietala Sven-Ola   Damber Jan-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 2, 1999-08 ,pp. : 89-93

Informa Healthcare

Access to resources Recommend Favorite

Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era

By Gilliland F.D.   Hunt W.C.   Key C.R.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite

Metastatic prostate cancer with normal level of serum prostate-specific antigen

By Nishio R.   Furuya Y.   Nagakawa O.   Fuse H.  

International Urology and Nephrology, Vol. 35, Iss. 2, 2003-01 ,pp. : 189-192

Springer Publishing Company

Access to resources Recommend Favorite

Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer

By Chen Y.-T.   Luderer A.A.   Thiel R.P.   Carlson G.   Cuny C.L.   Soriano T.F.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 518-524

Elsevier

Access to resources Recommend Favorite

Comparison of serum prostate-specific antigen levels and PSA density in african-american, white, and hispanic men without prostate cancer

By Abdalla I.   Ray P.   Ray V.   Vaida F.   Vijayakumar S.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 300-305

Elsevier

Access to resources Recommend Favorite